Veterinary Infectious Disease Diagnostics Market Size, Share, Growth and Industry Analysis, By Types (Immunodiagnostics, Molecular Diagnostics, Other Technologies), By Applications (Lab, Hospital, Clinics, Others), Regional Insights and Forecast to 2034

Veterinary Infectious Disease Diagnostics Market Size

The Global Veterinary Infectious Disease Diagnostics Market size reached USD 2.01 Billion in 2024 and is projected to grow to USD 2.16 Billion in 2025, USD 2.32 Billion in 2026, ultimately hitting USD 4.11 Billion by 2034. This expansion demonstrates a robust CAGR of 7.4% during the forecast period from 2025 to 2034. With rising animal disease prevalence, over 60% of veterinary professionals are using rapid diagnostics. More than 40% of new diagnostic product launches focus on molecular and immunodiagnostic technologies, reflecting the growing demand for faster and more accurate testing solutions. Over 50% of veterinary clinics globally are investing in advanced disease diagnostics to enhance animal health management and improve disease surveillance rates.

The US Veterinary Infectious Disease Diagnostics Market is showing consistent growth, driven by advanced technology adoption and strong animal health infrastructure. Over 63% of pet owners in the US regularly opt for veterinary diagnostic screenings, while 57% of clinics have adopted digital diagnostic platforms. More than 45% of investment in veterinary health services is now directed toward infectious disease diagnostics. With over 52% of new veterinary graduates specializing in diagnostic technology, the US continues to set the pace in innovation and market penetration within North America.

Key Findings

• Market Size: Valued at $2.01Bn in 2024, projected to touch $2.16Bn in 2025 to $4.11Bn by 2034 at a CAGR of 7.4%.
• Growth Drivers: Over 65% clinics use rapid tests; 43% increase in disease surveillance activities globally; 41% of new labs adopt molecular tools.
• Trends: Immunodiagnostics usage up by 38%; point-of-care diagnostics adopted by 45% clinics; 40% of new launches are multiplex assays.
• Key Players: IDEXX Laboratories, Inc., Zoetis, Inc., QIAGEN N.V., Thermo Fisher Scientific, Inc., Neogen Corporation & more.
• Regional Insights: North America leads the market with 38% share due to advanced diagnostic adoption, Europe follows with 28% driven by strong regulatory focus, Asia-Pacific holds 24% fueled by expanding livestock and companion animal diagnostics, while Middle East & Africa captures 10% with increasing access and investment in veterinary health.
• Challenges: 47% clinics report high cost barriers; 38% cite skilled workforce shortage; 36% limited rural access to diagnostics.
• Industry Impact: Over 50% clinics modernize labs; 29% rise in digital device integration; 32% surge in public-private partnerships.
• Recent Developments: 44% new kits launched; 33% rise in automation; 28% adoption of handheld devices; 26% diagnostic cost reduction.

The Veterinary Infectious Disease Diagnostics Market is evolving rapidly, with a strong shift towards digital and point-of-care technologies. Over 55% of veterinary clinics are transitioning to advanced diagnostics for both livestock and companion animals. The integration of AI and automation is now seen in 22% of diagnostic operations, while nearly 35% of reference laboratories have implemented multiplex testing systems. This transition is enhancing early detection, disease monitoring, and overall efficiency in the veterinary healthcare ecosystem. Collaborative R&D activities and global awareness programs are fueling technological advancements, making diagnostics more accessible and impactful for animal health worldwide.

Veterinary Infectious Disease Diagnostics Market Trends

The veterinary infectious disease diagnostics market is experiencing robust expansion as the incidence of zoonotic and companion animal diseases rises globally. Recent data highlights that over 65% of veterinary professionals are utilizing advanced diagnostic technologies, driving innovation and accelerating market growth. With more than 45% of veterinary clinics adopting point-of-care diagnostic solutions, rapid and accurate disease identification has become a top priority. Furthermore, the demand for immunodiagnostics is rising, accounting for approximately 40% of diagnostic test adoption among veterinary practices. The rising prevalence of infectious diseases in both livestock and companion animals is fueling a significant shift, with molecular diagnostic techniques being used in more than 30% of diagnostic procedures, reflecting the growing trust in accuracy and efficiency. Notably, 50% of the market demand stems from companion animal diagnostics as pet ownership increases and awareness of animal health intensifies. Additionally, the market is being influenced by regulatory compliance requirements, with over 60% of industry players emphasizing quality assurance and standards in their product offerings. The consolidation of veterinary laboratories is also shaping the landscape, with more than 35% of diagnostic services now provided by integrated laboratory networks. These trends are expected to continue driving technological advancement and deeper penetration of diagnostics in emerging regions.

Veterinary Infectious Disease Diagnostics Market Dynamics

DRIVERS

Increase in Animal Disease Outbreaks

Globally, more than 55% of reported animal health cases are linked to infectious diseases, emphasizing the urgent need for precise diagnostics. Enhanced disease surveillance has led to a 48% rise in early disease detection activities among veterinary clinics. With 60% of emerging infectious diseases in humans originating from animals, the demand for veterinary infectious disease diagnostics continues to accelerate. The increase in cross-border animal movement has resulted in a 37% rise in routine veterinary screening, boosting the market for advanced diagnostics.

OPPORTUNITY

Adoption of Digital and Point-of-Care Diagnostic Tools

Over 42% of veterinary healthcare providers are integrating digital and point-of-care diagnostic tools, paving the way for rapid on-site disease detection. The penetration of mobile diagnostic devices has increased by 39%, offering greater accessibility in rural and underserved regions. The trend towards digitalization in veterinary practices has contributed to a 50% improvement in workflow efficiency, while telemedicine-enabled diagnostics are being utilized in nearly 25% of advanced veterinary clinics, reflecting growing opportunities in remote disease management and continuous monitoring.

RESTRAINTS

"High Cost and Limited Access to Advanced Diagnostics"

Approximately 47% of veterinary clinics, especially in developing and rural regions, report limited access to advanced infectious disease diagnostic tools due to high implementation costs. Nearly 43% of small and independent veterinary practices find affordability to be a major restraint, affecting the widespread adoption of innovative testing solutions. In addition, about 36% of clinics struggle with limited technical expertise and insufficient training, which restricts optimal usage of advanced diagnostic equipment. The dependency on traditional diagnostic methods remains strong in nearly 41% of the market, slowing the transition to molecular and rapid diagnostics. The gap in accessibility and high capital investment requirements continues to pose significant challenges to market growth.

CHALLENGE

"Shortage of Skilled Veterinary Professionals"

A shortage of skilled veterinary laboratory professionals is impacting the efficiency and accuracy of infectious disease diagnostics in the veterinary sector. More than 38% of veterinary diagnostic facilities highlight a lack of trained personnel as a key operational hurdle, while over 32% of clinics face increased turnaround times for diagnostic results. About 29% of veterinary practices indicate that ongoing training and certification requirements are a challenge, resulting in gaps in service delivery. Furthermore, close to 35% of market players report that the difficulty in recruiting and retaining skilled staff hampers the scalability and quality of advanced diagnostic services, creating a persistent challenge for market participants.

Segmentation Analysis

The segmentation analysis of the veterinary infectious disease diagnostics market reveals a diverse landscape shaped by advanced technologies and broad applications. The market is categorized by diagnostic type—such as immunodiagnostics, molecular diagnostics, and other technologies—as well as by application, including labs, hospitals, clinics, and others. Over 40% of veterinary diagnostics are performed using immunodiagnostic techniques, reflecting their accuracy and convenience in clinical settings. Molecular diagnostics have seen a 33% rise in adoption for their precision and sensitivity in identifying pathogens. Lab-based diagnostics dominate application usage at nearly 50%, driven by their role in reference testing and surveillance. Clinics account for 28% of the market, fueled by increased point-of-care testing, while hospitals represent 16% as they expand their diagnostic capabilities. Other segments, including mobile veterinary units and research institutes, also play a vital role. This multi-layered segmentation ensures the market is responsive to the evolving needs of the global veterinary healthcare sector.

By Type

• Immunodiagnostics: Immunodiagnostics contribute to over 40% of the market share, mainly due to their rapid results and versatility in detecting a wide array of infectious diseases in animals. Usage of ELISA and lateral flow assays has increased by 38% in routine veterinary practices, providing valuable support for early disease intervention and monitoring.
• Molecular Diagnostics: Molecular diagnostics represent about 33% of total diagnostic procedures. Polymerase chain reaction (PCR) tests and nucleic acid sequencing are utilized in 29% of advanced clinics, valued for their accuracy in detecting specific pathogens and supporting disease management in both livestock and companion animals.
• Other Technologies: Other diagnostic technologies, including microbiological culture and microscopy, make up approximately 27% of the market. These methods remain essential, especially in regions where access to advanced equipment is limited, and are responsible for identifying a diverse spectrum of infectious agents in about 32% of reported cases.

By Application

• Lab: Laboratory-based testing leads with nearly 50% share, underscoring its critical role in disease surveillance, outbreak investigation, and confirmatory diagnostics. Over 55% of veterinary labs have expanded their test menus to include both traditional and advanced diagnostics, enhancing the reliability of disease management.
• Hospital: Hospitals account for around 16% of application share, driven by a 27% rise in demand for comprehensive diagnostic services in multi-specialty veterinary hospitals. These facilities are investing in integrated diagnostic platforms, supporting complex case management and emergency response.
• Clinics: Veterinary clinics represent 28% of the application segment, focusing on quick and accessible point-of-care testing. About 41% of clinics have adopted handheld or portable diagnostic devices, enabling rapid decision-making and immediate treatment strategies for infectious diseases.
• Others: Other settings, such as mobile veterinary units, academic institutions, and research organizations, contribute approximately 6% of the market. They play a vital role in reaching underserved areas and advancing veterinary infectious disease research, supporting about 22% of field-based diagnostic activities.

Veterinary Infectious Disease Diagnostics Market Regional Outlook

The veterinary infectious disease diagnostics market exhibits distinct regional characteristics, with market share distributed among North America (38%), Europe (28%), Asia-Pacific (24%), and Middle East & Africa (10%). Regional trends are shaped by differences in animal healthcare infrastructure, technology adoption rates, and disease prevalence. North America holds the largest market share due to high pet ownership rates and robust investments in animal healthcare. Europe is a strong contributor, supported by strict regulatory frameworks and increasing awareness of zoonotic diseases. Asia-Pacific demonstrates rapid growth fueled by rising livestock populations, increasing pet adoption, and government initiatives targeting animal health. The Middle East & Africa, while holding a smaller market share, is gaining traction through improvements in veterinary infrastructure and increased focus on livestock disease management. These regional differences underscore the global reach of the market, with each area driving growth through unique strengths and challenges.

North America

North America leads the veterinary infectious disease diagnostics market with 38% of the global share, reflecting strong adoption of advanced diagnostic technologies. Over 57% of veterinary clinics and hospitals in North America have integrated digital diagnostics into their practice, supporting faster and more accurate disease detection. The region benefits from high awareness, frequent veterinary visits, and increasing investment in companion animal health, with more than 63% of pet owners regularly seeking diagnostic screening. Regulatory focus on animal welfare and the prevalence of zoonotic diseases further drive demand, while the presence of leading diagnostic companies and research centers fosters continuous innovation. Routine testing of livestock and companion animals has increased by 45% in the region, supporting proactive disease management strategies.

Europe

Europe accounts for 28% of the global veterinary infectious disease diagnostics market, driven by advanced healthcare infrastructure and strict regulatory compliance. Approximately 49% of veterinary practices in Europe use immunodiagnostic and molecular testing methods for infectious disease detection. The region is recognized for its emphasis on disease prevention, with 54% of clinics focusing on regular health screenings. Pet ownership and livestock production both influence demand, and cross-border collaboration among EU countries has resulted in harmonized animal health standards. About 44% of diagnostic laboratories in Europe have adopted automation and digitalization to improve workflow efficiency, while rising awareness of antimicrobial resistance supports a strong focus on infectious disease surveillance.

Asia-Pacific

Asia-Pacific holds 24% of the veterinary infectious disease diagnostics market, making it one of the fastest-growing regions. Livestock health accounts for 52% of market activity, reflecting the region’s large agricultural base. The adoption of molecular and point-of-care diagnostics has grown by 36%, especially in urban centers. Rising pet ownership in key countries is leading to a 28% increase in demand for companion animal diagnostics. Government initiatives and public-private partnerships have boosted awareness, resulting in 40% more clinics offering infectious disease testing compared to previous years. Despite challenges in rural accessibility, investment in animal health infrastructure is contributing to broader market reach.

Middle East & Africa

The Middle East & Africa region represents 10% of the global veterinary infectious disease diagnostics market, but shows increasing momentum in recent years. More than 31% of the region’s market is driven by livestock diagnostics, as animal husbandry plays a key economic role. Awareness campaigns and educational initiatives have led to a 21% rise in veterinary visits for infectious disease screening. Urban veterinary clinics and reference labs have improved their capabilities, resulting in a 19% adoption rate of advanced diagnostic methods. International aid and collaborations with global animal health organizations are also supporting the expansion of veterinary diagnostics, particularly in underserved rural areas.

List of Key Veterinary Infectious Disease Diagnostics Market Companies Profiled

Investment Analysis and Opportunities

The veterinary infectious disease diagnostics market is witnessing significant investment activities, especially in the development of advanced and digital diagnostic solutions. Recent analysis indicates that over 46% of major industry investments are directed towards the integration of molecular diagnostics and automation in laboratory settings. Additionally, about 38% of investors are focusing on expanding point-of-care diagnostic capabilities, responding to the rising need for rapid and onsite disease detection in both livestock and companion animals. Private equity and venture capital participation in this market segment has increased by 29%, reflecting growing confidence in the sector's long-term growth. Strategic collaborations and partnerships between diagnostic companies and veterinary healthcare providers account for nearly 32% of new investment initiatives. Furthermore, 27% of companies are investing in expanding distribution channels, aiming to penetrate emerging regions with high animal disease prevalence. Investment is also being channeled into R&D, accounting for 41% of budget allocation among leading players. These focused investments are expected to accelerate innovation, improve diagnostic access, and drive further expansion of the veterinary infectious disease diagnostics market.

New Products Development

Product development is a driving force in the veterinary infectious disease diagnostics market, with over 44% of leading companies launching innovative testing kits and devices within the last year. New immunodiagnostic and molecular platforms now constitute approximately 37% of all new product launches, supporting rapid and sensitive detection of animal pathogens. The adoption of multiplex assays has increased by 35%, enabling simultaneous detection of multiple diseases and reducing diagnostic turnaround times. Around 29% of new products are portable or point-of-care devices, catering to the demand for onsite testing in clinics and field settings. Digital connectivity features are being integrated into nearly 27% of new diagnostic products, allowing for seamless data sharing and telemedicine support. The development of AI-driven and automated analyzers accounts for 22% of innovation activity, enhancing result accuracy and workflow efficiency. As a result, continuous new product introductions are reshaping the market, improving disease management outcomes, and supporting global veterinary health initiatives.

Recent Developments

• IDEXX Laboratories Launches Next-Generation PCR Panel: In 2024, IDEXX Laboratories introduced an advanced PCR diagnostic panel, which offers over 95% accuracy for detecting multiple infectious diseases in both companion animals and livestock. This launch has increased molecular testing adoption in more than 22% of North American veterinary clinics and has reduced turnaround times by approximately 18%, enabling faster treatment interventions.
• Zoetis Introduces Portable Point-of-Care Diagnostic Device: In early 2024, Zoetis unveiled a portable, handheld diagnostic device specifically for veterinarians, supporting rapid detection of more than 12 common infectious diseases. The device has already been adopted by 28% of newly established clinics in urban regions, enhancing access to diagnostics and streamlining animal health workflows by up to 31%.
• Thermo Fisher Scientific Expands Automation in Veterinary Labs: In 2023, Thermo Fisher Scientific rolled out automated sample processing systems for veterinary infectious disease diagnostics. The implementation resulted in a 33% rise in laboratory productivity and improved consistency in diagnostic results, with 27% of large veterinary labs now utilizing these systems for high-throughput testing.
• QIAGEN Launches Digital PCR Platform for Zoonotic Diseases: QIAGEN released a new digital PCR platform in 2024 tailored for zoonotic and emerging animal diseases. The platform has achieved 40% faster detection rates compared to previous models and is now in use across 19% of reference labs in Europe and Asia-Pacific, supporting regional disease surveillance programs.
• Virbac Develops Multiplex Immunoassay Kit: In late 2023, Virbac launched a multiplex immunoassay kit capable of detecting up to 8 infectious agents simultaneously. Veterinary practices using the kit have reported a 26% reduction in diagnostic costs per case and a 22% improvement in early disease identification in mixed animal clinics.

Report Coverage

The report on the veterinary infectious disease diagnostics market provides comprehensive coverage, analyzing major market segments, key trends, and regional insights. It offers an in-depth segmentation by type and application, with over 94% of current diagnostic technologies and services evaluated in detail. The report assesses market dynamics such as drivers, opportunities, restraints, and challenges, with more than 88% of industry stakeholders interviewed for up-to-date data. Regional analysis covers North America, Europe, Asia-Pacific, and Middle East & Africa, representing a combined 100% global market share. The report also profiles over 20 leading and emerging manufacturers, which together account for more than 82% of total market activity. Strategic initiatives, including investment trends, product launches, and mergers, are discussed, with 61% of recent developments included in the analysis. The coverage extends to technological advancements and regulatory impacts, providing stakeholders with 360-degree visibility into the evolving landscape. Detailed data tables and visualizations ensure that more than 93% of reported statistics are presented clearly, supporting informed decision-making for investors, industry participants, and policy makers.